ArticleAnnals of translational medicine2021

Phospho-EGFRTyr992 is synergistically repressed by co-inhibition of histone deacetylase (HDAC) and phosphatidylinositol 3-kinase (PI3K), which attenuates resistance to erlotinib in head and neck cancer cells.

Xuejun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.